The technology uses non-nutritive sweeteners or polyols as imaging agents for MRI and PET detection of tissue accumulation.
Phospholipid encapsulation enables enhanced ultrasound contrast and localized delivery of therapeutic gases following hypoxic-ischemic injury.
Leveraging open-source AI platforms, this technology enables automated image-based detection, prediction, and control of microfluidic single bubble/droplet formation.
3D printing filaments for 3D printing phantoms with controlled iodine concentrations for precise, adjustable spectral CT imaging research and calibration.
A radio frequency-based 3D imaging system that can generate LiDAR-comparable images with reduced power and processing needs.
A tissue-selective, biocompatible contrast agent enables the visual identification of tumors and tumor margins during procedures
Small molecules that bind to alpha-synuclein deposition and can be used for PET imagining in patients with synucleinopathies
A nuclear magnetic resonance (NMR) based enzyme-detection system comprising xenon (129Xe) biosensors complexed with an enzyme-specific peptide substrate.
Device for the optimal mixing and delivery of MRI gaseous contrast agents
Hyperpolarized xenon chemical exchange saturation transfer (CEST) contrast agent for molecular imaging